Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntercede Regulatory News (IGP)

Share Price Information for Intercede (IGP)

Share Price is delayed by 15 minutes
Get Live Data
120.50    2.50 (2.12%)
Bid:
118.00
Ask:
123.00
Spread: 5.00 (4.237%)
Market Cap: £72.50m
IGP Live PriceLast checked at - London Stock Exchange

Intraday Intercede Share Chart

Trading Update

11 Apr 2008 07:00

Intercede Group PLC11 April 2008 11 APRIL 2008 INTERCEDE GROUP PLC ("Intercede" or "the Company") Trading Update for the Full Year to 31 March 2008 On 14 February 2008, Intercede announced a number of new contract wins, andfurther progress on several existing projects. As it enters its closed periodahead of announcing full year results for the financial year ended 31 March2008, Intercede is pleased to report that it continues to experience high levelsof interest in and demand for its MyID technology. Good progress has been made with all of the projects referred to in theCompany's previous announcement. Intercede has also been engaged with a numberof new prospects. To put this in perspective, the Group is currently involved insignificant work on over 10 major projects whereas, as recently as 2 years ago,Intercede was typically only working on 2 major projects at a time. The momentumis therefore clearly building and we are increasingly confident that this willbe reflected in future financial performance as more and more projects movebeyond the initial POC and pilot phases. Significant progress has also been made during the past year with thedevelopment of MyID Version 8.0 which is scheduled for launch during the currentquarter. MyID Version 8.0 represents a substantial strengthening and broadeningof the Group's historical card management offering since it is the only solutionof its kind to deliver registration, ID verification and card/device issuanceand life cycle management within a single product. Pre audit indications of the results for the year ended 31 March 2008 are thatrevenues have increased from £2.6m to £2.8m. Costs continue to be tightlycontrolled and have been maintained at the same level as the prior yearresulting in a substantial reduction in last year's operating loss of £0.3m.Year end cash balances totalled £1.15m. Intercede expects to announce its full year results for the year ended 31 March2008 by early June 2008. About Intercede Intercede Group plc is a leading developer and supplier of smart card andidentity management software listed on the London Stock Exchange (IGP LN)(IGP.L). Intercede's MyID software manages the secure registration, issuance andlifecycle of digital identities for a wide range of uses. This requires theintegration of multiple technologies and products from many different vendors,including smart cards, biometrics, digital certificates, Open Platform appletsand physical access control systems. Intercede works with a number of market leading OEM, re-seller and technologypartners that supply MyID technology to the global market place including:Athena Smartcard Solutions, Gemalto, Oberthur Card Systems, Oracle, RSASecurity, SafeNet, Thales, VeriSign and a variety of systems integrators andother security product and service providers. Intercede and MyID are registered trademarks or trademarks in the UK, US and/orother countries. For more information visit http://www.intercede.com ENQUIRIES Intercede Group plc Tel. +44 (0)1455 558111Richard Parris, Chairman & Chief ExecutiveAndrew Walker, Finance Director KBC Peel Hunt Tel. +44 (0)20 7418 8900Richard KaufferDaniel Harris Pelham Public RelationsArchie Berens Tel. +44 (0)20 7743 6679 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
26th Nov 20247:00 amRNSTransaction in Own Shares
25th Nov 20247:00 amRNSTransaction in Own Shares
22nd Nov 20247:00 amRNSTransaction in Own Shares
19th Nov 20247:00 amRNSTransaction in Own Shares
18th Nov 20247:00 amRNSTransaction in Own Shares
15th Nov 20247:00 amRNSTransaction in Own Shares
14th Nov 20247:00 amRNSTransaction in Own Shares
13th Nov 20247:00 amRNSTransaction in Own Shares
12th Nov 20247:00 amRNSTransaction in Own Shares
11th Nov 20247:00 amRNSTransaction in Own Shares
8th Nov 20247:00 amRNSTransaction in Own Shares
4th Nov 20247:00 amRNSNotice of Results & Investor Presentation
25th Oct 20247:00 amRNSShare Buyback Programme
11th Oct 20248:38 amRNSDirector/PDMR Shareholding
8th Oct 20247:00 amRNSTrading Update
1st Oct 20247:00 amRNSNotification of Trading Update and H1 FY25 Results
30th Sep 20247:00 amRNSContract Orders and Renewals
25th Sep 202412:51 pmRNSResult of AGM
20th Sep 202411:45 amRNSDirector/PDMR Shareholding
18th Sep 20247:00 amRNSContract Orders and Renewals
2nd Sep 20247:00 amRNSContract Orders and Subscription Renewals
30th Aug 20247:00 amRNSNotice of AGM and Publication of Annual Report
4th Jul 20243:58 pmRNSIssue of Equity & Total Voting Rights
28th Jun 20243:49 pmRNSIssue of Equity & Total Voting Rights
26th Jun 20247:00 amRNSPartnership with Carahsoft Technology Corp
19th Jun 20246:25 pmRNSHolding(s) in Company
18th Jun 20249:17 amRNSHolding(s) in Company
18th Jun 20247:15 amRNSDirector/PDMR Shareholding and Issue of Equity
18th Jun 20247:00 amRNSFinal Results
5th Jun 20247:00 amRNSNotice of Results & Investor Presentation
16th May 202412:00 pmRNSCapital Markets Day - Agenda Update
14th May 20246:17 pmRNSShare Incentive Scheme
26th Apr 202410:02 amRNSShare Incentive Scheme
23rd Apr 20247:00 amRNSCapital Markets Day
8th Apr 20247:00 amRNSTrading Update
2nd Apr 20247:00 amRNSContract and Subscription Renewals
25th Mar 20243:38 pmRNSHolding(s) in Company
25th Mar 20243:35 pmRNSHolding(s) in Company
22nd Mar 20247:00 amRNSNew Orders and Trading Update
21st Mar 20247:00 amRNSNew Product Announcement: Launch of MyID MFA v5
6th Feb 20247:00 amRNSDirector/PDMR Shareholding
29th Jan 20247:00 amRNSNew Orders
18th Jan 20249:55 amRNSDirector/PDMR Shareholding
3rd Jan 20247:00 amRNSMajor New Contract Win
7th Dec 20237:00 amRNSUpdate on Major New Contract Win
5th Dec 202312:30 pmRNSMajor New Contract with Large US Federal Agency
22nd Nov 20237:00 amRNSDirector/PDMR Shareholding
21st Nov 20237:01 amRNSNew Contract and Renewal Orders
21st Nov 20237:00 amRNSHalf-year Report
7th Nov 20237:00 amRNSContract and Renewals Orders

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.